Position in PTGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$122,369
+$20,968 QoQ
Shares Held
1,161
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Truvestments Capital LLC holds $1,930,996 across 60 Biotechnology names. PTGX ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
7,726 | $331,368 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,257 | $150,059 | |
| 3 | CTMX |
CytomX Therapeutics, Inc.
|
27,428 | $128,911 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
This page
|
1,161 | $122,369 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
3,680 | $101,936 | |
| 6 | KALV |
KalVista Pharmaceuticals, Inc.
|
4,684 | $94,288 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,155 | $85,770 | |
| 8 | DBVT |
DBV Technologies S.A.
|
3,892 | $81,303 |
All Filings in PTGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,369 | 1,161 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $101,401 | 1,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,962 | 722 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,925 | 650 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,589 | 281 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,056 | 131 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,895 | 131 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $3,789 | 131 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,003 | 131 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,185 | 131 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,618 | 131 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,013 | 131 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,763 | 345 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,908 | 345 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,728 | 345 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $8,550 | 250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,430 | 250 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $11,220 | 250 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,475 | 250 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,399 | 119 | Shares | Sole | 2021-02-17 | |
| 2020-06-30 | $2,101 | 119 | Shares | Sole | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||